We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
BioNeutra Global Corporation | TSXV:BGA | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.04 | 0.04 | 0.065 | 0 | 01:00:00 |
RNS Number:7857S Barlo Group PLC 02 December 2003 Barlo Group plc On 11 July 2003 it was announced that Barlo Group Plc ("Barlo" or "the Company") had received an approach from its Chief Executive, Dr. Anthony Mullins on behalf of himself and other members of the management team of the Company, which may or may not lead to an offer being made for the Company and which was made on the basis of an offer price of Euro0.30 for each ordinary share in the capital of the Company (a "Barlo Share"). In response to recent media speculation, the Company announces that the approach has been revised to a basis of an offer price of Euro0.40 per Barlo Share. It is further understood that the offer, if made, will be made by Melgan Limited (a company formed under the direction of Dr. Mullins) ("Melgan"). The Committee of the Board of Barlo (comprising Mr. Niall Carroll and Mr. John Farrell) (the "Committee") is considering this approach, which may or may not lead to an offer being made for the Company. The Committee and Melgan are in discussions with a view to having a firm intention to make an offer announcement issued by mid January. The revised approach does not constitute a firm intention to make an offer and, therefore, there can be no certainty that an offer will result. A holder of 1% or more of the shares of Barlo may have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2001, effective from 11 July 2003. Enquiries: Mon O'Driscoll Managing Director, AIB Corporate Finance Tel: + 353 1 667 0233 Mr. Niall Carroll Chairman, Barlo Group plc Tel: + 353 1 260 0966 Mr. Jim Milton Murray Consultants Limited Tel: + 353 1 632 6400 Mob: + 353 86 255 8400 Mr. Tom Byrne Murray Consultants Limited Tel: + 353 1 498 0339 Mob: +353 86 810 4224 AIB Corporate Finance Limited, which is regulated in Ireland by the Irish Financial Services Regulatory Authority under the Investment Intermediaries Act, 1995, is acting for Barlo and for no one else in relation to the matters described in this announcement and will not be responsible to anyone other than Barlo for providing the protections afforded to clients of AIB Corporate Finance Limited or for providing advice in relation to the matters described in this announcement. This announcement does not constitute an offer or an invitation to purchase any securities. The Directors of Barlo accept responsibility for all the information contained in this announcement. To the best of the knowledge and belief of the Directors of Barlo (who have each taken all reasonable care to ensure that such is the case), the information contained in this announcement is in accordance with the facts and does not contain anything likely to affect the import of such information. This information is provided by RNS The company news service from the London Stock Exchange END OFDNKBKPOBDDPBK
1 Year BioNeutra Global Chart |
1 Month BioNeutra Global Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions